HIF-2α inhibitors and targeted therapies represent a novel approach in the management of advanced renal cell carcinoma (RCC) (1). These agents act on critical tumour-promoting pathways, including angiogenesis and cellular proliferation, to control disease progression (1). By specifically targeting mechanisms that drive tumour growth, they offer new
Male with Urethral Bleeding due to Insertion of Telephone Wire in Urethra
2466 Reached4 Comments6 Likes
Male Complaining of Bilateral Knee Pain and Gait Disturbance
840 Reached5 Comments1 Likes
FOURIER Trial: Efficacy of Evolocumab in Managing Cardiovascular Events
563 Reached3 Comments
Study evaluating Effectiveness of Bacillus clausii for Treatment of Rotavirus Infection
1303 Reached4 Comments6 Likes
Vildagliptin in Reducing Risk of Post-partum Diabetes
2385 Reached7 Comments4 Likes